Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies
Abstract: Immuno‐oncology therapies have the potential to revolutionize the armamentarium of available cancer treatments. To further improve clinical response rates, researchers are looking for novel combination regimens, with checkpoint blockade being used as a backbone of the treatment. This Review highlights the significance of small molecules in this approach, which holds promise to provide increased benefit to cancer patients.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies ; volume:57 ; number:16 ; year:2018 ; pages:4412-4428 ; extent:17
Angewandte Chemie / International edition. International edition ; 57, Heft 16 (2018), 4412-4428 (gesamt 17)
- Creator
-
Huck, Bayard R.
Kötzner, Lisa
Urbahns, Klaus
- DOI
-
10.1002/anie.201707816
- URN
-
urn:nbn:de:101:1-2022091007232272595242
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Huck, Bayard R.
- Kötzner, Lisa
- Urbahns, Klaus
Other Objects (12)
Immuno-oncology
Immuno-Oncology
Personalized Immuno-Oncology
Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations
Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies
Statistical issues and challenges in immuno-oncology
Advancing translational research for colorectal immuno-oncology
Targeted Therapies in Pediatric Oncology
Immunodynamics of explanted human tumors for immuno‐oncology
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies
Novel strategies for immuno-oncology breakthroughs with cell therapy
Ultrasound in the Assessment of Tumor Response in the Age of Targeted and Immuno-Oncology Therapies. Back to the Future
Immuno-oncology
Immuno-Oncology
Personalized Immuno-Oncology
Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations
Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies
Statistical issues and challenges in immuno-oncology
Advancing translational research for colorectal immuno-oncology
Targeted Therapies in Pediatric Oncology
Immunodynamics of explanted human tumors for immuno‐oncology
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies
Novel strategies for immuno-oncology breakthroughs with cell therapy
Ultrasound in the Assessment of Tumor Response in the Age of Targeted and Immuno-Oncology Therapies. Back to the Future
Immuno-oncology
Immuno-Oncology
Personalized Immuno-Oncology
Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations
Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies
Statistical issues and challenges in immuno-oncology
Advancing translational research for colorectal immuno-oncology
Targeted Therapies in Pediatric Oncology
Immunodynamics of explanted human tumors for immuno‐oncology
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies
Novel strategies for immuno-oncology breakthroughs with cell therapy